Among OPTEL’s many satisfied customers is Thermo Fisher Scientific, who recognises the value OPTEL’s serialisation and track and trace capabilities can provide beyond compliance.
Thermo Fisher Scientific recently expanded its packaging and serialisation capabilities at its facility in Greenville, North Carolina, part of its Patheon global CDMO network. The company has built a new filling and packaging suite and upgraded another of its packaging lines with new technology to improve efficiency and reduce change-over time.
The newly constructed 4,800 square-foot suite came online in late 2017 and features a filling and packaging line equipped with an Optel serialisation system. The state-of-the-art system includes cameras, pharma proof stations, line master and bottle and bundle tracker equipment. This addition means that Thermo Fisher now offers 17 operational serialisation lines, with plans to activate another ten by the end of 2018.
“We recognise the importance of serialisation to our customers and Thermo Fisher will be ready globally to comply with individual regional or country requirements,” said Chris Howell, senior director of global engineering and technology. “Besides meeting the important compliance requirements, serialisation data may also provide insights into commercial channels, giving customers the ability to track distribution and the location of specific packages. This can provide significant value, for inventory management, field recalls, sales data and, importantly, to combat counterfeit products.”
With the deadline for complying with the Drug Supply Chain Security Act (DSCSA) in the US looming, there is an uptick in activity and preparation. The state of serialisation readiness varies across regions since countries have different timelines, South Korea and China, like Turkey, have already implemented serialisation. Thermo Fisher has implemented serialisation globally and will be able to meet the US deadline of November 26, 2018, as well as the EU deadline of February 2019.
To find out more please fill out the enquiry form.